Oncologists weighted how to choose, manage, and deliver new therapeutics beyond major academic centers. Across many disease ...

October 23, 2026 - DelveInsight's " BCG-Unresponsive Non-Muscle Invasive Bladder Cancer – Market Insights, Epidemiology, and Market Forecast – 2034 " report delivers an in-depth understanding of ...

BCG vaccination reduced tau pathology and neuroinflammation in mice, prompting researchers to investigate whether trained immunity could inform future treatments for Alzheimer’s disease.

Database lock completed for Cohort A of QUILT-2.005 (NCT02138734), a randomized, controlled registrational trial comparing ANKTIVA® plus BCG with BCG alone in 366 patients with BCG-naïve non-muscle ...

Based on early research, @HopkinsMedicine investigators are moving the field closer to understanding links between the #Tuberculosis vaccine and reduced risks for #Dementia while expanding knowledge ...

Since BCG's 2024 AI Maturity Matrix, Japan and South Korea Join Canada, Mainland China, Singapore, the UK, and the US as AI Pioneers New BCG Research Finds AI Readiness Has Significantly Advanced ...

New BCG Survey Reveals 65% of Revenue Leaders Expect Headcount to Grow, 72% Expect Budgets to Rise, and 91% Expect Higher Quotas or Productivity Requirements per SellerAI Expected to Help ...

Alongside urinary symptoms, the regimen can cause systemic effects such as chills, fever, and musculoskeletal pain. Eppie ...

(NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ANKTIVA ® (nogapendekin alfa ...

The UAE ranks first globally in citizen satisfaction with government digital services, with 89% of respondents rating them ...